Also Known As
Protein C Activity
Protein C Level
Protein S Activity
Protein S Level
Formal Name
Protein C, Functional or Antigen; Protein S, Functional or Antigen (Free or Total)
This article was last reviewed on
This article waslast modified on
May 28, 2018.
At a Glance
Why Get Tested?

To help evaluate inappropriate blood clot formation (thrombotic episode or thromboembolism); to determine whether you may have a protein C or protein S deficiency

When To Get Tested?

When you have had an unexplained blood clot; when your newborn has a severe clotting disorder; sometimes when a close relative has an inherited protein C or protein S deficiency

Sample Required?

A blood sample drawn from a vein in your arm

Test Preparation Needed?

You must wait at least 10 days after a thrombotic episode and be off oral warfarin (Coumadin®) anticoagulant therapy for 2 weeks before having this test done. (See also Common Questions #1.)

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

What is being tested?

Protein C and protein S are two proteins in the blood that help regulate blood clot formation. Two separate tests for these proteins are often performed together as part of the investigation of a possible excessive clotting disorder. The tests measure the amount of each protein and evaluate whether they are performing their proper functions.

Normally, when a body tissue or blood vessel wall is injured, a process called hemostasis begins to form a plug at the injury site to help stop the bleeding. Small cell fragments called platelets adhere to and aggregate at the site and a coagulation cascade begins as proteins called coagulation factors are activated one after the other. Eventually, a stable clot forms, preventing additional blood loss and remaining in place until the injured area has healed. The clot is then broken down when it is no longer needed. There must be an adequate amount of platelets and clotting factors and each must function normally in order for a stable clot to form.

Proteins C and protein S work together to help control blood clot formation. They inactivate specific coagulation factors (factors V and VIII) that are required to generate and form blood clots. This has the net effect of slowing down clot formation, much like brakes slow a speeding car. However, if there is not enough protein C or S or they are not functioning normally, clot formation can go unchecked, possibly leading to excessive clotting. These conditions can range from mild to severe.

Deficient or dysfunctional protein C or protein S may be due to an underlying condition (acquired), such as liver disease, kidney disease, severe infections or cancer, or can be inherited, passed from parent to child. About 1 out of every 300 people has one normal gene and one abnormal gene (heterozygous) for protein C deficiency and about 1 in 20,000 people have protein S or C deficiencies that lead to symptoms.

There are two types of inherited protein C deficiencies:

  • Type 1 is related to quantity.
  • Type 2 is related to abnormal function and is less common than Type 1.

Protein S exists in two forms in the blood: free and bound to another protein, but only the free protein S is available to combine with protein C. There are three types of inherited protein S deficiencies:

  • Type 1 deficiency is due to an insufficient quantity.
  • Type 2 is due to abnormal function.
  • Type 3 is due to low free protein S levels, though total protein S levels are normal.

Two types of tests may be used to evaluate protein C and protein S:

  • Functional tests for protein C and protein S measure their activity and evaluate their ability to regulate and slow blood clotting. Decreased activity may be due to a decreased amount of protein C or S or, more rarely, due to dysfunctional protein C or S.
  • Protein C and protein S antigen tests measure the amount of the protein present. Protein S antigen tests measure either free protein S or total protein S or both.

How is the sample collected for testing?

A blood sample is obtained by inserting a needle into a vein in the arm.

Is any test preparation needed to ensure the quality of the sample?

You must wait at least 10 days after a thrombotic episode and be off oral warfarin (Coumadin®) anticoagulant therapy for 2 weeks before having this test done. (See also Common Questions #1.)

Accordion Title
Common Questions
  • How is it used?

    Tests for protein C and protein S are two separate tests that are often performed together to help investigate a possible excessive clotting (hypercoagulable) disorder and/or to help diagnose the cause of an inappropriate blood clot such as deep venous thrombosis (DVT) or a venous thromboembolism (VTE).

    Normally, protein S combines with protein C and together they help control blood clot formation. However, if there is not enough protein C or S or they are not functioning normally, clot formation can go unchecked, possibly leading to an excessive clotting disorder.

    Testing is used to evaluate people who have unexplained blood clots or a family history of blood clots, especially if the blood clot occurs in a relatively young person (less than 50 years old) or has formed in an unusual location, such as the veins leading to the liver or kidney or the blood vessels of the brain. It may also be used when someone has had multiple miscarriages. While immediate treatment of the VTE does not depend on the test result, a health practitioner will want to determine the cause and the likelihood of recurrent clotting once the affected person's condition has stabilized.

    Tests for protein C and protein S measure their function (activity) or quantity (antigen):

    • Functional tests for protein C and protein S are usually ordered, along with other tests for excessive clotting, to screen for normal factor activity.
    • Based on the functional test results, quantities of protein C antigen and free, or sometimes total, protein S antigen may be measured to look for decreased production due to an acquired or inherited condition, to determine the severity, and to classify the type of deficiency. For protein S, the free protein antigen test is recommended rather than an activity test for initial detection of an inherited deficiency because there are other conditions that can interfere with functional testing. If the protein S or C shortage is due to a rare inherited genetic change, the quantity of protein C or protein S available and the degree of activity can be used to help determine whether a person has one copy (heterozygous) or two copies (homozygous) of the mutation.

    A health practitioner will also likely order other tests to look for underlying diseases or conditions, such as liver disease, vitamin K deficiency, or cancer, that may cause inappropriate blood clotting (bleeding or thrombosis).

  • When is it ordered?

    Protein C and protein S tests are ordered when a person has had a thrombotic episode or thromboembolism, especially when the affected person is relatively young (less than 50 years old) and/or does not have any other obvious reasons for developing a blood clot.

    Protein C and protein S tests should not, however, be ordered for at least 10 days after the episode, and they should not be ordered while a person is on oral warfarin (Coumadin®) anticoagulant therapy (see Common Questions #1). Usually this means that the health practitioner will treat a person's DVT or VTE, eliminate the immediate blood clotting threat, and put the person on a limited course of anticoagulant therapy (often about 3 to 6 months).

    When the person's situation has stabilized, the health practitioner will often order protein C and free protein S function/activity tests, along with other tests associated with excessive clotting, to help determine the cause of the blood clot and to help evaluate the risk of recurrence.

    Protein C and S tests may be ordered when a newborn has a severe clotting disorder, such as disseminated intravascular coagulation (DIC) or purpura fulminans.

    A test that shows decreased activity or quantity of protein C or protein S should be repeated on another occasion before a diagnosis can be made. If an acquired deficiency is identified, protein C or protein S levels may be re-checked occasionally as the underlying condition progresses or is resolved. Once an inherited deficiency is confirmed, the health practitioner will keep it in mind when the patient is exposed to situations that increase his or her risk of clotting, such as surgery, chemotherapy for cancer, or oral contraceptive use.

    Although protein C and protein S tests are not recommended as routine screens, they may sometimes be ordered when someone has a close relative with an inherited protein C or protein S deficiency, especially if the person affected has a severe form or had their first VTE at a young age.

  • What does the test result mean?

    Elevated protein C and/or elevated protein S are not usually associated with medical problems or considered clinically significant.

    Normal activity and level of protein C and protein S usually indicate adequate clotting regulation.

    Low protein C or protein S level or activity can result in excessive or inappropriate blood clotting. If the protein is dysfunctional (normal levels of protein, but it does not work correctly), the coagulation process will not be sufficiently regulated. Either situation can lead to an increased risk of developing a clot that blocks the flow of blood in the veins, but the severity of the risk depends on the magnitude of the deficiency and/or the degree of dysfunction of the protein.

    Acquired deficiencies

    Low protein C and protein S may be related to insufficient production or to increased use. Since both proteins are produced in the liver and are vitamin K-dependent, liver disease, vitamin K deficiency, or warfarin (Coumadin®) anticoagulant therapy that opposes vitamin K may result in reduced protein C and/or protein S levels. Conditions such as disseminated intravascular coagulation (DIC) that cause clotting and bleeding simultaneously throughout the body use up clotting factors, including protein C and protein S, at an increased rate and so decrease their levels in the blood.

    Low protein C and low protein S may be seen with severe infections, inflammatory conditions, kidney disease, cancers, treatment with certain chemotherapeutic agents, HIV, during pregnancy, immediately following a thrombotic episode, and with warfarin (Coumadin®) anticoagulant therapy. These conditions reflect the decreased production or increased use of protein C and/or protein S. They may be mild and temporary (as with pregnancy) or have variable severity and be acute, chronic, or progressive.

    Inherited deficiencies

    Although inherited mutations in the genes that produce protein C and protein S are relatively rare, they can result in:

    • Decreased production of protein C or protein S
    • Abnormal protein C or S that cannot bind properly to the other to form a functional activated protein C complex
    • Abnormal protein that can bind and form a protein C complex, but the complex is not capable of inactivating specific coagulation factors VIII and V as it normally does
    • Abnormal protein S that is cleared more rapidly by the body, as seen in Type 3 deficiency

    When these mutations occur, they are independent of each other and the mutation is most likely to be in one or the other (protein C or protein S). Mutations in the gene may occur in one gene copy or two gene copies (heterozygous or homozygous). A heterozygous mutation raises the risk of developing a DVT and/or VTE a moderate amount, but a homozygous mutation in either protein C or S gene can cause severe clotting – it may cause life-threatening purpura fulminans or DIC in the newborn and it requires a lifetime of vigilance against recurrent thrombotic episodes.

    There are three types of inherited protein S deficiencies associated with being heterozygous for protein S deficiency. People who are heterozygous for protein S deficiency have a 10 fold increased risk for VTE. Results that may be seen with the three types of deficiency are summarized below. The most common types are 1 and 3.

    Type of
    Deficiency
    Free protein STotal protein S antigenTotal protein S Activity
    1 Decreased Decreased Decreased
    2 Normal Normal Decreased
    3 Decreased Normal Decreased
  • Is there anything else I should know?

    If other factor deficiencies, such as decreased antithrombin, or inherited conditions such as Factor V Leiden or prothrombin 20210 mutation are also present, the effects of a protein C or protein S deficiency can be exacerbated.

    Fresh frozen plasma contains protein C and protein S, and it can be used as a short-term preventative when a patient is having a surgical procedure.

    Activated protein C is being investigated as therapy for the treatment of patients with sepsis, but this agent has generally not been used in patients with protein C deficiency. A protein C concentrate was approved by the FDA for use in patients with protein C deficiency. However, its use remains controversial.

  • I am on anticoagulant therapy. Can I still have this test done?

    If you are on anticoagulation therapy, your healthcare provider may need to consult an expert on coagulation testing and decide if the protein C and/or protein S activity assay can be reliably performed and interpreted. Anticoagulant drugs may either alter protein C and protein S levels or interfere with the protein C and protein S activity assays; therefore, the treatment may have to be stopped for a period of time before blood samples are collected for the tests.

  • Is there anything I can do to increase protein C and protein S levels?

    Not directly. If you have deficiencies that are due to a temporary condition (such as pregnancy or an infection), they should return to normal levels by themselves. If they are due to an underlying condition, like liver disease or vitamin K deficiency, then that condition must be addressed. If you have inherited protein C or protein S deficiencies or dysfunction, your healthcare provider will often advise you to concentrate on lowering other clotting risk factors. This may include lowering elevated homocysteine levels, not smoking, and avoiding oral contraceptive use. When necessary, fresh frozen plasma, which contains protein C and protein S, can be given as a short-term preventative measure (for instance, before a surgical procedure), but this is not a treatment that can be used on a daily basis.

  • Should relatives of someone with an inherited protein C or protein S deficiency be tested?

    Not necessarily. Routine screening has not been recommended because the penetrance of the genes is low. This means that even if you have the genetic change, you may or may not ever have a clotting problem. Your healthcare provider may want to order this testing, however, if you have a strong family history of a severe protein C or protein S deficiency or a history of developing a thrombosis at an early age.

View Sources

Sources Used in Current Review

Chen, Yi-Ben. et. al. (Updated 2013 March 3). Protein C. MedlinePlus Medical Encyclopedia. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003659.htm through http://www.nlm.nih.gov/. Accessed October 2014.

Gersten, T. et. al. (Updated 2012 February 8). Congenital protein C or S deficiency. MedlinePlus Medical Encyclopedia. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000559.htm through http://www.nlm.nih.gov/. Accessed October 2014.

Cuker, A. and Pollak, E. (Updated 2013 March 5). Protein C Deficiency. eMedicine. Available online at http://emedicine.medscape.com/article/205470-overview through http://emedicine.medscape.com. Accessed October 2014.

(Reviewed 2013 May). Protein C deficiency. Genetics Home Reference. Available online at http://ghr.nlm.nih.gov/condition/protein-c-deficiency through http://ghr.nlm.nih.gov. Accessed October 2014.

(Reviewed 2009 October). Protein S deficiency. Genetics Home Reference.Available online at http://ghr.nlm.nih.gov/condition/protein-s-deficiency through http://ghr.nlm.nih.gov. Accessed October 2014.

(© 1995-2014) Protein S Activity, Plasma. Mayo Medical Laboratories. http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/80775 through http://www.mayomedicallaboratories.com. Accessed October 2014.

Sadaka, F. et al. Activated protein C in septic shock: a propensity matched analysis. Critical Care 2011, 15: R89. doi:10.1186/cc10089. Available online at http://ccforum.com/content/15/2/R89 through http://ccforum.com. Accessed October 2014.

Godwin, J. (Updated 2012 January 10). Protein S Deficiency. eMedicine. Available online at http://emedicine.medscape.com/article/205582-overview through http://emedicine.medscape.com. Accessed October 2014.

Pagana, K. D. & Pagana, T. J. (© 2012). Mosby's Diagnostic and Laboratory Test Reference 11th Edition: Mosby, Inc., Saint Louis, MO. Pp 767-768.

National Blood Clot Alliance. Protein C deficiency. Available online at http://www.stoptheclot.org/News/article136.htm through http://www.stoptheclot.org. Accessed October 2014.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

Gardner, B. (2001 April 3). Protein C Deficiency. Medscape Primary Care, Pediatrics Ask the Expert [Online information]. Available online at http://www.medscape.com/viewarticle/413850_print through http://www.medscape.com.

Coagulation Test Panels. Florida Hospital Cancer Institute, Clinical and Research Laboratories [Online information]. Available online at http://www.fhci-labs.com/researchlabs/clinicallabs/hemostasisandthrombosis/panels.htm through http://www.fhci-labs.com.

Confusing Coagulation Test Names. UAB Coagulation Service, Univ of Alabama at Birmingham [Online information]. Available online at http://peir.path.uab.edu/coag/article_187.shtml and Protein C Activity, Activated Protein C Resistance (Screen for Factor V Leiden) at http://peir.path.uab.edu/coag/cat_index_14.shtml#191 through http://peir.path.uab.edu.

Schlesinger, K. and Ragni, M. (2002). DIC, Inflammation, Sepsis And Activated Protein C (APC). Transfusion Medicine Update, Issue #3 [On-line information]. Available online at http://www.annals.org/issues/v135n5/full/200109040-00013.html through http://www.annals.org.

Chapter 132 Thrombotic Disorders, General. The Merck Manual of Diagnosis and Therapy, Section 11. Hematology And Oncology [Online information]. Available online at http://www.merck.com/pubs/mmanual/section11/chapter132/132a.htm through http://www.merck.com.

Protein C Deficiency. University of Illinois - Urbana/Champaign, Carle Cancer Center, Hematology Resource Page, Patient Resources [On-line information]. Available online at http://www-admin.med.uiuc.edu/hematology/PtProtC.htm through http://www-admin.med.uiuc.edu.

Protein S Deficiency. University of Illinois - Urbana/Champaign, Carle Cancer Center, Hematology Resource Page, Patient Resources [On-line information]. Available online at http://www-admin.med.uiuc.edu/hematology/PtProtS.htm through http://www-admin.med.uiuc.edu.

Bardi, J. (2002). Mysteries of a Therapy Unveiled. The Scripps Research Institute, News & Views [On-line Newsletter]. Available online at http://www.scripps.edu/newsandviews/e_20020617/print-ruf.html through http://www.scripps.edu.

Elstrom, R. (2001 October 28, Updated). Protein C. MedlinePlus Health Information, Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003659.htm.

Elstrom, R. (2001 October 28, Updated). Protein S. MedlinePlus Health Information, Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003660.htm.

Coagulation Test Panels. Clinical and Research Laboratories, Florida Hospital Cancer Institute [On-line information]. Available online at http://www.fhci-labs.com/researchlabs/clinicallabs/hemostasisandthrombosis/panels.htm through http://www.fhci-labs.com.

Laposata, M. & Vancott, E. (2000 January). How to work up hypercoagulability. CAP In the News [On-line Coagulation Case Study]. Available online at http://www.cap.org/CAPToday/casestudy/coag5.html through http://www.cap.org.

Venomous Bites and Stings. The Merck Manual of Medical Information-Home Edition, Section 24. Accidents and Injuries, Chapter 287 [On-line information]. Available online at http://www.merck.com/mrkshared/mmanual_home/sec24/287.jsp through http://www.merck.com.

Menta, S. (1999 Spring). The Coagulation Cascade. Physiology Disorders Evaluation, College of Medicine, Univ of Florida [On-line information]. Available online at http://www.medinfo.ufl.edu/year2/coag/title.html through http://www.medinfo.ufl.edu.

Bauer, K. (2001). The Thrombophilias: Well-Defined Risk Factors with Uncertain Therapeutic Implications. Ann Intern Med. 2001;135:367-373 [Journal]. Available online through http://www.annals.org.

DeLoughery, T. (1999 March 15). Tests of Hemostasis and Thrombosis. OHSU [Online student handout]. Available online at http://www.ohsu.edu/som-hemonc/handouts/deloughery/printtest.html through http://www.ohsu.edu.

(2001 January 10, Modified). Coagulation Test Descriptions. Clinical Coagulation Laboratory, A division of Duke University Regional Referral Laboratory Services [Online information]. Available online at http://pathology.mc.duke.edu/coag/TestDes.htm through http://pathology.mc.duke.edu.

Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. P 781-782.

Nanda, R. (2005 April 15). Congenital protein C or S deficiency. MedlinePlus [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000559.htm. Accessed on 3/25/07.

Nanda, R. (2005 April 15). Protein C. MedlinePlus [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003659.htm. Accessed on 3/25/07.

Nanda, R. (2005 April 15). Protein S. MedlinePlus [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003660.htm. Accessed on 3/25/07.

(© 2007). Laboratory Issues in Diagnosing Abnormalities of Protein C, Thrombomodulin, and Endothelial Cell Protein C Receptor. CAP [On-line information]. Available online through http://www.cap.org. Accessed on 3/25/07.

(© 2007). A Review of the Technical, Diagnostic, and Epidemiological Considerations for Protein S Assays. CAP [On-line information]. Available online through http://www.cap.org. Accessed on 3/25/07.

Dugdale, D. et. al. (Updated 2009 March 2). Protein C. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003659.htm. Accessed September 2010.

Dugdale, D. et. al. (Updated 2010 March 28). Congenital protein C or S deficiency. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000559.htm. Accessed September 2010.

Cuker, A. and Pollak, E. (Updated 2009 June 11). Protein C Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/205470-overview through http://emedicine.medscape.com. Accessed September 2010.

(Reviewed 2009 October). Protein C deficiency. Genetics Home Reference [On-line information]. Available online at http://ghr.nlm.nih.gov/condition/protein-c-deficiency through http://ghr.nlm.nih.gov. Accessed September 2010.

(Reviewed 2009 October). Protein S deficiency. Genetics Home Reference [On-line information]. Available online at http://ghr.nlm.nih.gov/condition/protein-s-deficiency through http://ghr.nlm.nih.gov. Accessed September 2010.

Spence, R. et. al. (Updated 2010 January 12). Hemostatic Disorders, Nonplatelet eMedicine. [On-line information]. Available online at http://emedicine.medscape.com/article/210467-overview through http://www.nlm.nih.gov. Accessed September 2010.

Godwin, J. (Updated 2009 August 27). Protein S Deficiency. eMedicine [On-line information]. Available online at http://emedicine.medscape.com/article/205582-overview through http://emedicine.medscape.com. Accessed September 2010.

Pagana, K. D. & Pagana, T. J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 781-782.

Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 922-923, 926-927.

National Blood Clot Alliance. Protein C deficiency. Available online at http://www.stoptheclot.org/News/article136.htm through http://www.stoptheclot.org. Accessed September 2010.

National Blood Clot Alliance. Protein S deficiency: a clinical perspective. Available online at http://www.stoptheclot.org/News/article137.htm through http://www.stoptheclot.org. Accessed September 2010.

Ask a Laboratory Scientist

 

Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, the American Society for Clinical Laboratory Science (ASCLS). Click on the Contact a Scientist button below to be re-directed to the ASCLS site to complete a request form. If your question relates to this web site and not to a specific lab test, please submit it via our Contact Us page instead. Thank you.

Contact a Scientist